Stock screener

EQ

Conviction 55HealthcareScan · Mon, Aug 10, 2026
Bullish engulfing
EQ$2.18+3.32%
ResistanceSupportVol 14Insider sell
63 bars
2
4
Vol MA14 554.84K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Equillium, Inc.PHARMACEUTICAL PREPARATIONSwww.equilliumbio.com ↗
Price2.18
Change+3.32%
Gap-0.47%
Rel volume3.11×
Avg volume504.25K
Avg $ vol1.2M
SMA 202.41
SMA 502.72
SMA 2001.89
Price vs 50-19.75%
Price vs 200+15.44%
MA stackmixed
50/200 cross—
Supertrenddown · 2.70
RSI (14)38
MACD hist-0.03
MACD cross—
Stoch %K / %D19 / 9
ADX (14)22
+DI / −DI12 / 22
RSI divergence—
MACD divergence—
ATR %+9.60%
ADR %8.20%
52w high3.20
52w low0.4952
From 52w high-31.87%
Above 52w low+340.23%
New 52w highNo
SqueezeOff
Bollinger width35.01%
%B0.23
Donchian pos17.02%
Donchian high2.96
Donchian low2.02
AVWAP (52w high)2.80
vs AVWAP high-22.04%
AVWAP (52w low)1.40
vs AVWAP low+55.86%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d3.11×
Avg vol (14d)554.84K
Avg vol (20d)504.25K
Avg $ vol (20d)1.2M
Market cap137.83M
RS 3m (vs SPY)-7.10%
RS 6m (vs SPY)+28.45%
RS line new highNo
Trend template5/8
Technical rank54.9
1 week-0.91%
1 month-25.09%
3 months+3.32%
6 months+43.42%
1 year+294.21%
YTD+42.48%
P/E-6.15
P/B2.32
P/S3.35
P/FCF-6.05
EPS-0.3900
Div yield—
ROE-37.65%
ROA-35.51%
Debt/Eq0.13
Current18.62
EV/EBITDA-3.57
Gross margin—
Net margin-54.50%
Rev growth0.00%
EPS growth-177.65%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value84.07M
Revenue12.16M
Net income-5.31M
Gross profit—
Free cash flow-22.79M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out63.23M
Employees14
ListedFri, Oct 12, 2018
Free float44.78M
Float %70.8%
Short interest5.57M
Days to cover4.5d
Short volume30.5%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.06 vs −$0.04
Last surprise-50.0% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank54.9 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EQ

All disclosures →
No recent disclosed trades by Congress in EQ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EQ · 5 buys · 5 sells

InsiderSideShares
Zedelmayer Christine
Sr. Vice President and COO · Employee Stock Option (right to buy) · 2026-06-05
Exercise14.58K
Zedelmayer Christine
Sr. Vice President and COO · Common Stock · 2026-06-05
Exercise14.58K
Connelly Stephen
President and CSO · Common Stock · 2026-06-05
Sell30.98K
Zedelmayer Christine
Sr. Vice President and COO · Common Stock · 2026-06-05
Sell14.58K
Connelly Stephen
President and CSO · Common Stock · 2026-06-04
Sell200K
BRADBURY DANIEL
CHAIRMAN · Director stock option (right to buy) · 2026-05-28
Grant70K
McDermott Charles Douglas
Director · Director Stock Option (right to buy) · 2026-05-28
Grant70K
Zedelmayer Christine
Sr. Vice President and COO · Common Stock · 2026-05-28
Exercise14.58K
Zedelmayer Christine
Sr. Vice President and COO · Employee Stock Option (right to buy) · 2026-05-28
Exercise7.29K
Tom Penny
Principal Accounting Officer · Common Stock · 2026-05-28
Exercise65K

SEC filings

EDGAR filings in EQ · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.